Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Drug-Related Side Effects and Adverse Reactions × Infliximab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 2 Colitis 2 Urogenital Neoplasms 1 Skin Neoplasms 1 Drug-Related Side Effects and Adverse Reactions 1 Colitis, Ulcerative 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Social Determinants of Health 2 Prednisone 1 Methylprednisolone Hemisuccinate 1 Methylprednisolone 1 Infliximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04305145 2026-01-29

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

Massachusetts General Hospital

Phase 2 Active not recruiting

Colitis, Melanoma, Skin Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon ⚡